Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees
Author(s) -
Jennifer Goldman,
Troy Richardson,
Jason G. Newland,
Brian Lee,
Jeffrey S. Gerber,
Matt Hall,
Matthew P. Kronman,
Adam L. Hersh
Publication year - 2016
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piv106
Subject(s) - medicine , antimicrobial stewardship , antimicrobial , emergency department , medicaid , emergency medicine , ambulatory , cohort , intensive care medicine , health care , antibiotics , antibiotic resistance , chemistry , organic chemistry , psychiatry , microbiology and biotechnology , economics , biology , economic growth
Outpatient parenteral antimicrobial therapy (OPAT) is overused in cases where highly bioavailable oral alternatives would be equally effective. However, the scope of OPAT use for children nationwide is poorly understood. Our objective was to characterize OPAT use and clinical outcomes for a large population of pediatric Medicaid enrollees treated with OPAT.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom